347
Participants
Start Date
April 19, 2012
Primary Completion Date
March 6, 2018
Study Completion Date
March 6, 2018
Albumin 5%
Therapeutic plasma exchange with human albumin 5%
Albumin 20%
Low volume plasma exchange with human albumin 5%
Immunoglobulin
Intravenous human immunoglobulin 5%
University of Pittsburgh Medical Center, Pittsburgh
Parc Hospitalari Martí i Julià, Girona
Howard University, Washington D.C.
Hospital Universitari de Santa Maria, Lleida
Hospital General Universitario Gregorio Marañón, Madrid
Hospital Clínico San Carlos, Madrid
Hospital Universitario de Getafe, Getafe
Roper St. Francis Healthcare, Charleston
iResearch Atlanta, LLC, Decatur
RTR Medical Group, Savannah
Neurology Associates of Osmond Beach, Ormond Beach
Galiz Research, LLC, Hialeah
Quantum Laboratories, Deerfield Beach
L&L Research Choices, Inc, Miami
Allied Biomedical Research Institute, Miami
Miami Dade Medical Research Institute, LLC, Miami
Largo Medical Center, Largo
PharmaSeek LLC (DMI Research), Pinellas Park
Bradenton Research Center, Inc., Bradenton
Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife
Wesley Neurology Clinic, Cordova
The Cleveland Clinic Foundation, Cleveland
Neurology Specialists Inc, Dayton
Hospital Universitario Doctor Peset, Valencia
Hospital Universitario y Politécnico La Fe, Valencia
Hospital Viamed Montecanal, Zaragoza
Mountain View Clinical Research, Inc, Denver
Northern California Research, Sacramento
Dartmouth-Hitchcock Medical Center, Lebanon
The NeuroCognitive Institute, Mount Arlington
Mid-Atlantic Geriatric/ARC, Paterson
Hospital General de Elche, Elche
Hospital Universitario del Vinalopó, Elche
Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat
Hospital General de Catalunya, Sant Cugat del Vallès
Hospital Universitari Mútua de Terrassa, Terrassa
Fundació ACE, Barcelona
Hospital Vall d'Hebrón, Barcelona
Hospital de la Santa Creu i Sant Pau, Barcelona
Hospital Universitario de Burgos, Burgos
Grifols Biologicals, LLC
INDUSTRY
Instituto Grifols, S.A.
INDUSTRY